-ADDF STATEMENT ON FDA DECISION NOT TO GRANT ACCELERATED APPROVAL TO DONANEMAB FOR TREATMENT OF ALZHEIMER'S DISEASE

Media coverage

• Title	-ADDF STATEMENT ON FDA DECISION NOT TO GRANT ACCELERATED APPROVAL TO DONANEMAB FOR TREATMENT OF ALZHEIMER'S DISEASE
  Media name/outlet	M2 PressWIRE
  Country/Territory	United Kingdom
  Date	23/01/23
  URL	ct.moreover.com/?a=49819077426&p=1gw&v=1&x=X4eG87Ml5l3MV8NKCLg_4Q
  Persons	Howard Fillit

• Title	-ADDF STATEMENT ON FDA DECISION NOT TO GRANT ACCELERATED APPROVAL TO DONANEMAB FOR TREATMENT OF ALZHEIMER'S DISEASE
  Media name/outlet	ENP Newswire
  Date	23/01/23
  URL	ct.moreover.com/?a=49819079723&p=1gw&v=1&x=Dt-Ynfu8XrdKfGZuWwCI7A
  Persons	Howard Fillit